Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd.

4166.TWO
Orient Pharma Co., Ltd.TW flagTaipei Exchange
25.90
TWD
+0.50
- -
6.29BMarket Cap

Orient Pharma Co., Ltd. (4166.TWO) Stock Split History

Learn about Orient Pharma Co., Ltd.'s most recent 541-for-500 basis stock split on July 08, 2020. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Orient Pharma Co., Ltd.'s most recent stock split

Split Date: 2020-07-08
Split Ratio: 541:500
Price Before Split: $14.39
Price After Split: $13.30

Developer API

Get 4166.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/4166.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.08 times more shares (a 541:500 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Orient Pharma Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-07-08541:500No$14.39$13.30
2016-06-06333:500Yes$15.20$10.13

About Orient Pharma Co., Ltd.

Company overview and industry information

Orient Pharma Co., Ltd. (4166.TWO) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 541-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Orient Pharma Co., Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.